Atlas Trials

Theriva Biologics SL

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Theriva Biologics SL

RecordFirmDate
A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer (NCT07701486)Theriva Biologics SL2026-08-03
Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer (NCT05673811)Theriva Biologics SL2023-01-10
A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer (NCT02045589)Theriva Biologics SL2014-01-01
Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors (NCT02045602)Theriva Biologics SL2014-01-01

Track Theriva Biologics SL automatically

Every clearance here is in the API, with alerts when new ones post.